Cargando…

Emerging strategies for treating metastasis

The systemic spread of tumor cells is the ultimate cause of the majority of deaths from cancer, yet few successful therapeutic strategies have emerged to specifically target metastasis. Here we discuss recent advances in our understanding of tumor-intrinsic pathways driving metastatic colonization a...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Mark, Ganesan, Shridar, Kang, Yibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064405/
https://www.ncbi.nlm.nih.gov/pubmed/33899000
http://dx.doi.org/10.1038/s43018-021-00181-0
_version_ 1783682128241754112
author Esposito, Mark
Ganesan, Shridar
Kang, Yibin
author_facet Esposito, Mark
Ganesan, Shridar
Kang, Yibin
author_sort Esposito, Mark
collection PubMed
description The systemic spread of tumor cells is the ultimate cause of the majority of deaths from cancer, yet few successful therapeutic strategies have emerged to specifically target metastasis. Here we discuss recent advances in our understanding of tumor-intrinsic pathways driving metastatic colonization and therapeutic resistance, as well as immune activating strategies to target metastatic disease. We focus on therapeutically exploitable mechanisms, promising strategies in preclinical and clinical development, and emerging areas with potential to become innovative treatments.
format Online
Article
Text
id pubmed-8064405
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-80644052021-09-01 Emerging strategies for treating metastasis Esposito, Mark Ganesan, Shridar Kang, Yibin Nat Cancer Article The systemic spread of tumor cells is the ultimate cause of the majority of deaths from cancer, yet few successful therapeutic strategies have emerged to specifically target metastasis. Here we discuss recent advances in our understanding of tumor-intrinsic pathways driving metastatic colonization and therapeutic resistance, as well as immune activating strategies to target metastatic disease. We focus on therapeutically exploitable mechanisms, promising strategies in preclinical and clinical development, and emerging areas with potential to become innovative treatments. 2021-03-24 2021-03 /pmc/articles/PMC8064405/ /pubmed/33899000 http://dx.doi.org/10.1038/s43018-021-00181-0 Text en http://www.nature.com/authors/editorial_policies/license.html#termsUsers may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Esposito, Mark
Ganesan, Shridar
Kang, Yibin
Emerging strategies for treating metastasis
title Emerging strategies for treating metastasis
title_full Emerging strategies for treating metastasis
title_fullStr Emerging strategies for treating metastasis
title_full_unstemmed Emerging strategies for treating metastasis
title_short Emerging strategies for treating metastasis
title_sort emerging strategies for treating metastasis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064405/
https://www.ncbi.nlm.nih.gov/pubmed/33899000
http://dx.doi.org/10.1038/s43018-021-00181-0
work_keys_str_mv AT espositomark emergingstrategiesfortreatingmetastasis
AT ganesanshridar emergingstrategiesfortreatingmetastasis
AT kangyibin emergingstrategiesfortreatingmetastasis